545424-39-3

Basic information

• Product Name: Benzaldehyde, 4-(2-oxazolyl)-
• CAS NO: 545424-39-3
• Molecular Formula: C10H7NO2
• Molecular Weight: 173.171
• Mol File: 545424-39-3.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzaldehyde, 4-(2-oxazolyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 4-(2-oxazolyl)-(545424-39-3)
• EPA Substance Registry System: Benzaldehyde, 4-(2-oxazolyl)-(545424-39-3)

Safety Data

• Hazardous Substances Data: 545424-39-3(Hazardous Substances Data)

Upstream product

• 1055195-12-4 ethyl 2-(4-formylphenyl)oxazole-4-carboxylate 
• 125533-82-6 2-bromooxazole 
• 87199-17-5 4-formylphenylboronic acid, 
• 62882-04-6 2-(p-tolyl)oxazole 
• 34241-39-9 azobisisobutyronitrile 
• 421553-38-0 (4-Oxazol-2-yl-phenyl)-methanol 

Downstream Products

• 1029347-31-6 4-(2-oxazolyl)-phenyl-N-methyl-nitrone 

Relevant articles and documents

CYCLOALKANE-1,3-DIAMINE DERIVATIVE

The present invention provides a compound or a pharmaceutically acceptable salt thereof having an inhibitory action on the interaction between menin and an MLL protein. The compound represented by the formula (1) or a pharmaceutically acceptable salt thereof. wherein, in the formula (1), the dotted circle, R1, R2, R3, R4, R5, R6, R7, R8, Ring Q1, W, m and n are each as defined in the description.

Diaminopyrimidine derivatives as growth hormone secrectgogue receptor (GHS-R) antagonists

The present invention is related to compounds of formula (I), or a therapeutically suitable salt or prodrug thereof, the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by the action of ghrelin receptor, including Prader-Willi syndrome, eating disorder, weight gain, weight-loss maintainance following diet and exercise, obesity, and disorders associated with obesity such as noninsulin dependent diabetes mellitus.